Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addressing Cardiovascular Disease Multimorbidity in Patients Living With HIV in Nigeria

NCT07909395 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07909395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Addressing Cardiovascular Disease Multimorbidity in Patients Living With HIV in Nigeria
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2027
Completion date
August 31, 2030
Enrollment
1,050 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 3 arms.

  • R61 - Pilot PHCs ExperimentalHEARTS

    The HEARTS package will be pilot tested in 2 PHCs.

  • R33 - HEARTS Only Active comparatorHEARTS

    PHCs assigned to the standard care group, HEARTS only.

  • R33 - PF + HEARTS Package ExperimentalHEARTS, PF

    PHCs assigned to the PF + HEARTS implementation group.

Primary endpoints

Registered primary outcome measures; 3 primary.

  • Implementation Fidelity of HEARTS at 12 Months Month 12

    Fidelity is defined as the utilization of all components of the HEARTS program: identifying PLWH with uncontrolled hypertension (HTN) and diabetes mellitus (DM); measuring patient anthropometrics and BP; initiating lifestyle counseling and medication treatment every 1-3 months; and referring PLWH with complicated HTN and DM to physicians for further care.

  • Change in Systolic Blood Pressure (SBP) from Baseline to 12 Months Baseline, Month 12
  • Change in Hemoglobin A1c (HbA1c) from Baseline to 12 Months Baseline, Month 12

Lead sponsor's other trials

NYU Langone Health, most recent start first.

Similar trials

Same condition (Cardiovascular Diseases) and phase, most recent start first.